Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

June 01, 1988; Volume 33,Issue 6
  • You have access
    Multiple sites for the regulation of the N-methyl-D-aspartate receptor.
    I J Reynolds and R J Miller
    Molecular Pharmacology June 1988, 33 (6) 581-584;
  • You have access
    125I-BW-A844U, an antagonist radioligand with high affinity and selectivity for adenosine A1 receptors, and 125I-azido-BW-A844U, a photoaffinity label.
    A Patel, R H Craig, S M Daluge and J Linden
    Molecular Pharmacology June 1988, 33 (6) 585-591;
  • You have access
    Effects of cholera toxin on the coupling of thyrotropin-releasing hormone to a guanine nucleotide-binding protein in cultured GH3 cells.
    Y Yajima, Y Akita and T Saito
    Molecular Pharmacology June 1988, 33 (6) 592-597;
  • You have access
    ML-9 inhibits the vascular contraction via the inhibition of myosin light chain phosphorylation.
    T Ishikawa, T Chijiwa, M Hagiwara, S Mamiya, M Saitoh and H Hidaka
    Molecular Pharmacology June 1988, 33 (6) 598-603;
  • You have access
    Low concentration of reserpine accelerates actin polymerization via interaction with G-actin.
    S Nakamura, K Ohmi and Y Nonomura
    Molecular Pharmacology June 1988, 33 (6) 604-610;
  • You have access
    Messenger RNA loses the ability to direct in vitro peptide synthesis following incubation with cisplatin.
    J Rosenberg and P Sato
    Molecular Pharmacology June 1988, 33 (6) 611-616;
  • You have access
    Characterization of muscarinic receptors in guinea pig ileum longitudinal smooth muscle.
    E Giraldo, M A Viganò, R Hammer and H Ladinsky
    Molecular Pharmacology June 1988, 33 (6) 617-625;
  • You have access
    Kinetic studies on the mechanism by which histamine H1 receptors potentiate cyclic AMP accumulation in guinea pig cerebral cortical slices.
    J Donaldson, S J Hill and A M Brown
    Molecular Pharmacology June 1988, 33 (6) 626-633;
  • You have access
    Noncompetitive inhibitors reach their binding site in the acetylcholine receptor by two different paths.
    M Blanton, E McCardy, T Gallaher and H H Wang
    Molecular Pharmacology June 1988, 33 (6) 634-642;
  • You have access
    Long-lasting agonist activity produced by a capsaicin-like photoaffinity probe.
    I F James, C S Walpole, J Hixon, J N Wood and R Wrigglesworth
    Molecular Pharmacology June 1988, 33 (6) 643-649;
  • You have access
    Role of arachidonic acid metabolism in the mitogenic response of BALB/c 3T3 fibroblasts to epidermal growth factor.
    R D Nolan, R M Danilowicz and T E Eling
    Molecular Pharmacology June 1988, 33 (6) 650-656;
  • You have access
    Antidepressant binding to the porcine and human platelet serotonin transporters.
    C J Humphreys, J Levin and G Rudnick
    Molecular Pharmacology June 1988, 33 (6) 657-663;
  • You have access
    Role of phosphodiesterase in regulation of calcium current in isolated cardiac myocytes.
    M A Simmons and H C Hartzell
    Molecular Pharmacology June 1988, 33 (6) 664-671;
  • You have access
    Ketanserin binds to the monoamine transporter of chromaffin granules and of synaptic vesicles.
    F Darchen, D Scherman, P M Laduron and J P Henry
    Molecular Pharmacology June 1988, 33 (6) 672-677;
  • You have access
    Functional in vitro test of calmodulin antagonism: effect of drugs on interaction between calmodulin and glycolytic enzymes.
    F Orosz, T Y Christova and J Ovádi
    Molecular Pharmacology June 1988, 33 (6) 678-682;
  • You have access
    Substrate properties of analogs of myo-inositol.
    J D Moyer, O Reizes, S Ahir, C Jiang, N Malinowski and D C Baker
    Molecular Pharmacology June 1988, 33 (6) 683-689;
  • You have access
    Dopamine release and metabolism after chronic delivery of selective or nonselective dopamine autoreceptor agonists.
    C A Altar, B Berner, P Beall, S F Carlsen and W C Boyar
    Molecular Pharmacology June 1988, 33 (6) 690-695;
  • You have access
    Demonstration of a [K+,Cl-]-cotransport system in human red cells by its sensitivity to [(dihydroindenyl)oxy]alkanoic acids: regulation of cell swelling and distinction from the bumetanide-sensitive [Na+,K+,Cl-]-cotransport system.
    R P Garay, C Nazaret, P A Hannaert and E J Cragoe
    Molecular Pharmacology June 1988, 33 (6) 696-701;
  • You have access
    Stereoselectivity in the N'-oxidation of nicotine isomers by flavin-containing monooxygenase.
    L A Damani, W F Pool, P A Crooks, R K Kaderlik and D M Ziegler
    Molecular Pharmacology June 1988, 33 (6) 702-705;
  • You have access
    Partial characterization of specific cantharidin binding sites in mouse tissues.
    M J Graziano, I N Pessah, M Matsuzawa and J E Casida
    Molecular Pharmacology June 1988, 33 (6) 706-712;
  • You have access
    Effects of 9-(trans-2',trans-3'-dihydroxycyclopent-4'-enyl)-adenine and -3-deazaadenine on the metabolism of S-adenosylhomocysteine in mouse L929 cells.
    M Hasobe, J G Mckee, D R Borcherding, B T Keller and R T Borchardt
    Molecular Pharmacology June 1988, 33 (6) 713-720;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 33, Issue 6
1 Jun 1988
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics